Halozyme Therapeutics Inc

HALO

Company Profile

  • Business description

    Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

  • Contact

    12390 El Camino Real
    San DiegoCA92130
    USA

    T: +1 858 794-8889

    E: ir@halozyme.com

    https://www.halozyme.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    373

Stocks News & Analysis

stocks

Undervalued ASX share pulls a rabbit out of a hat

First quarter results are strong and debt levels have dropped.
stocks

The best tech stocks to buy

10 undervalued stocks offer attractive prices in a predominantly overvalued sector.
stocks

Microsoft earnings: Strength in cloud, guidance mixed

We think investors should be on board when Azure accelerates in the third quarter.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,422.8043.100.51%
CAC 407,409.1158.740.80%
DAX 4019,254.97177.430.93%
Dow JONES (US)42,052.19288.730.69%
FTSE 1008,177.1567.050.83%
HKSE20,569.4463.010.31%
NASDAQ18,239.92144.770.80%
Nikkei 22538,053.671,027.58-2.63%
NZX 50 Index12,590.6031.320.25%
S&P 5005,728.8023.350.41%
S&P/ASX 2008,164.6045.800.56%
SSE Composite Index3,305.0733.051.01%

Market Movers